1. Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
   Zachary Barry et al, 2020, Molecules CrossRef
2. TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling Pathways Involved in the Response to Xanthatin Treatment in Human HT-29 Colon Cancer Cells
   Aizong Shen et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
3. Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
   Hyeon Jeong Yoon et al, 2019, Medicina CrossRef
4. Xanthatin Alleviates LPS-Induced Inflammatory Response in RAW264.7 Macrophages by Inhibiting NF-κB, MAPK and STATs Activation
   Yuanqi Liu et al, 2022, Molecules CrossRef
5. Asparaginyl endopeptidase may promote liver sinusoidal endothelial cell angiogenesis via PI3K/Akt pathway
   Na Li et al, 2018, Revista Española de Enfermedades Digestivas CrossRef
6. Sorafenib Modulates the LPS- and Aβ-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice
   Jieun Kim et al, 2021, Frontiers in Immunology CrossRef